Pharma’s engagement with healthcare providers has slipped in recent years
Changing trends show a reduction in HCP contact with the pharma industry and an increased prioritisation of in-person contact.
AML cell therapy trials to watch in 2024 targeting GvHD
Acadia starts Phase III study of PWS therapy
Cybin reports positive results from major depressive disorder trial
World AIDS Day 2023 highlights community leadership to end the HIV epidemic
BioVie reports protocol deviations in Phase III Alzheimer’s trial
Analysis
View More
Themes
View MoreBerlin Cures announces expansion of long Covid drug study
The company aims to publish the first results from the trial next year.
More themes
Premium Insights
View MoreLeading innovators with viral vectors for the pharmaceutical industry
The pharmaceutical industry continues to be a hotbed of innovation, with activity driven by the evolution of new treatment paradigms,...
Discover premium insights powered by our properietary data
Understand the themes driving your sector, keep up with key innovation areas and track the activities of leading companies
More Insights
Buyer's Guides
View More
GlobalData Reports
View More
Digital Magazine
View MorePharma Technology Focus Magazine
Pharma Technology Focus is our digital magazine, free to read online on all devices. Click the magazine cover to read the latest issue. You can subscribe for free to have each new issue delivered to your inbox.
Junshi publishes positive Phase III results for Covid-19 pill VV116
University of Queensland’s vaccine shows virus-neutralising effect in trial
AIM ImmunoTech concludes dosing in Phase II post-Covid drug trial
COP27: Have we committed to our goals?